Actively Recruiting
REHABILITUS: A New Cognitive Remediation Tool for Adults With Intellectual Disability and Behavioral Disorders
Led by Hôpital le Vinatier · Updated on 2025-07-31
116
Participants Needed
1
Research Sites
28 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Adults with intellectual disabilities often face challenges in social situations due to difficulties in processing social information, especially in recognizing facial emotions. This research evaluates a cognitive remediation program called R e9habilitus, designed to improve attentional and visuospatial functions to reduce behavioral disorders in adults with intellectual disabilities who do not have autism spectrum disorder. The study aims to validate whether this program can help address specific cognitive and behavioral issues in daily life for this population. Participants are randomly assigned to either the R e9habilitus cognitive remediation program, which focuses on improving attention and spatial perception related to social behavior, or to a control group engaging in manual activities and computer-based research tasks. The study compares these two approaches to assess their effects on behavioral disorders and cognitive functions. During the study, participants are assessed on changes in hyperactivity and non-compliance behaviors using the Aberrant Behavior Checklist scale over six months. Researchers also measure improvements in facial emotion recognition and attentional functions at the start, end, and six months after the intervention. The total participation time and safety monitoring details are aligned with the evaluation periods, ensuring thorough follow-up to observe lasting effects.
CONDITIONS
Brief Title
A Computer-based Cognitive Remediation Program for Adults With Intellectual Disability
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 45 inclusive
- Behavioral disorders with a total score on the Aberrant Behavior Checklist above 15
- Presence of a family caregiver or professional involved in the project
- Diagnosis of mild to moderate intellectual disability assessed within the last 3 years
- French as primary or secondary language
- Psychoactive treatment unchanged during the month before inclusion
- Adult or legal representative has given written informed consent
- Affiliated with or beneficiary of a social security scheme
You will not qualify if you...
- Neurological disorders of vascular, infectious, or neurodegenerative origin
- Taking medications with neurological or psychiatric impact (e.g., corticosteroids)
- Participation in another cognitive remediation program targeting attention, visuospatial, or social cognition
- Refusal of participation by the person or legal representative
- Absence of a family or professional caregiver
- Presence of Autistic Spectrum Disorders evaluated if necessary
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants receive either the Réhabilitus cognitive remediation program focusing on attention and visuospatial functions or participate in manual activities and research computer information as part of the control group.
Weekly visits during the intervention period
Duration - 6 months
Participants are assessed to investigate the possible long-lasting effects of the intervention on behavioral disorders and cognitive functions.
1 visit at the end of the follow-up period
Trial Site Locations
Total: 1 location
1
Hopital Vinatier
Lyon, Auvergne-Rhône-Alpes, France, 69678
Actively Recruiting
Research Team
D
DEMILY CAROLINE, MD Ph
B
BABINET MARIE-NOELLE
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here